Karolinska University Hospital has, for the first time in Sweden, begun preparations to treat a patient with multiple myeloma ...

Karolinska University Hospital has, for the first time in Sweden, begun preparations to treat a patient with multiple myeloma ...

If approved, daratumumab will be the first authorised treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple myeloma, offering the potential for disease ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Paul Silvester, from Sheffield, was diagnosed with Myeloma in July 2023 after his cancer caused broken vertebrae in his spine ...

England’s NHS has launched a groundbreaking “Trojan Horse” therapy for the treatment of myeloma, offering hope for thousands ...

A "Trojan horse" therapy that sneaks toxic drugs inside cancer cells is being made available on the NHS in England in a world first. It can halt the blood cancer myeloma for nearly three times longer ...

The role of imaging in accurate classification and management of plasma cell disorders is substantial with the increasing evidence in the ability of cross-sectional imaging to identify disease related ...

In An Exercise in Uncertainty, Jon Gluck traces decades of waiting, watching, enduring experimental treatment, and miraculously beating the odds.

These conditions are described in Other Plasma Cell Disorders (below). Multiple myeloma can affect the blood, bones, and other organs, which can lead to problems in different parts of the body. In ...

Chimeric antigen receptor (CAR) T-cell therapy is a type of cancer immunotherapy. It helps the body’s own immune system find and attack cancer cells ... who have already received other types of ...